Amaducci, L, et al. Use of phosphatidylserine in Alzheimer's disease. Annals of the New York Academy of Science 640:245-249 (1991). Supplementation with phosphatidylserine, one of the phospholipids found in BIO-lipid, also produces an improvement in symptoms in Alzheimer's.

Amaducci L. (1988) Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study. Psychopharmacology Bulletin. 24(1):130-4.

Ames, BN, et al. Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences USA 90(17):7915-7922(1993). Oxidant by-products of metabolism cause significant damage to DNA, proteins and lipids. This damage results in aging and the degenerative diseases associated with aging, such as cancer, cardiovascular disease, immune system decline, brain dysfunction and cataracts. Antioxidant defenses against these diseases decline with age, necessitating the supplementation of antioxidants in the diet.

Bilikiewicz, A, Gaus, W. Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. Journal of Alzheimer’s Disease 6(1):17-26 (2004).

Crook, TH, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology 41(5):644-649 (1991). Patients with age-associated memory impairment showed significant improvement in memory performance tests with phosphatidylserine supplementation over a 12 week period.

Crook, T, et al. Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacology Bulletin 28(1):61-66 (1992). Another study which showed an improvement in symptoms of Alzheimer's with phosphatidylserine supplementation over 12 weeks. The less the impairment, the greater the improvement, suggesting that the earlier phosphatidylserine supplementation is begun in the course of the disease, the better the results will be.

Cross, CE, et al. Oxygen radicals and human disease. Annals of Internal Medicine 107(4):526-545 (1987). Oxygen free radicals, the by-products of normal metabolism, have been implicated in disease processes ranging from carcinogenesis to aging, emphasizing the importance of antioxidants in combating these conditions.

Leszek, J, et al. Colostrinin: proline-rich polypeptide complex from ovine colostrum - a long-term study of its efficacy in Alzheimer's disease. Medical Science Monitor 8(10):P193-P196 (2002). In a longer-term study, colostrinin produced improvement or stabilization in patients involved in the study.

Leszek, J, Inglot, AD, Janusz, M, Lisowski, J, Krukowska, K, Georgiades, JA. Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Archivum immunologiae et therapiae experimentalis (Warszava) 47(6):377-385 (1999).

Leszek, J, Inglot, AD, Janusz, M, Byczkiewicz, F, Kiejna, A, Georgiades, J, Lisowski, J. Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer's disease. Medical Science Monitor 8(10):193-196 (2002).

Mikulska, JE, Lisowski, J. A proline-rich polypeptide complex (PRP) from ovine colostrum. Studies on the effect of PRP on nitric oxide (NO) production induced by LPS in THP-1 cells. Immunopharmacology and Immunotoxicology 25(4):645-654 (2003).

Popik, P, Bobula, B, Janusz, M, Lisowski, J, Vetulani, J. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacology and Biochemistry of Behavior 64(1):183-189 (1999).

Popik, P, Galoch, Z, Janusz, M, Lisowski, J, Vetulani, J. Cognitive effects of Colostral-Val nonapeptide in aged rats. Behavioral Brain Research 118(2):201-208 (2001).

Stewart, MG, Banks, D. Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning paradigm. Neurobiology of Learning and Memory prepublication (2006).

Schuster, D, Rajendran, A, Hui, SW, Nicotera, T, Srikrishnan, T, Kruzel, ML. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid. Neuropeptides 39(4):419-426 (2005).

Zablocka, A, Janusz, M, Macala, J, Lisowski, J. A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice. Regulatory Peptides 125(1-3):35-39 (2005).

For Additional Links: www.scholar.google.com keywords: Colostrum, Alzheimer's

Ballard et. al. "Effects of anabolic agents on protein breakdown."Biochem J, 1983;210:243-249:

Gil, A. & Sanchez-Medina, F. "Acid soluble nucleotides of cow's, goat's and sheep's milk at different stages of lactation." Journal of Dairy Research, 1981;48:35-44.

Holbrook, N.J. & Ikeyama, S. "Age-related decline in cellular response to oxidative stress: links to growth factor signaling pathways with common defects." Biochem Pharmacol, 2002;64(5-6):999-1005.

Playford, R.J., et al. "Co-administration of the health food supplement, bovine colostrum, reduces the acute nonsteroidal anti-inflammatory drug-induced increase in intestinal permeability." Clin Sci (Lond), 2001;100(6):627-633.

Ullman, et al. "Effects of Growth Hormone on muscle regeneration and IgF-1 concentration in old rats." Acta Physiol Scand, 1990;140:521-525.

Xian, C.J., et al. "Degradation of IGF-1 in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein." Journal of Endocrinology, 1995;146:215-225.

For Additional Links: www.scholar.google.com keywords: Colostrum, Anti-aging

F. Runa Ali, A. Barry Kay, Mark Larché, The Potential of Peptide Immunotherapy in Allergy and Asthma , Current Allergy and Asthma Reports 2001.

"Allergy and Asthma"Institute of Chemistry and Biochemistry, Hellbrunner Str. 34, 5020 Salzburg, Austria. Univ.-Prof. Dr. Albert Duschl.

Elrod, KC, et al. Lactoferrin, a potent tryptase inhibitor, abolished late-phase airway responses in allergic sheep. American Journal of Respiratory Critical Care Medicine 156:375-381 (1997). Tryptase, a digestive enzyme, has been implicated in various aspects of asthma, including bronchoconstriction and airway hyperreactivity. Lactoferrin has been shown to inhibit tryptase activity, thus relieving the symptoms of asthma.

Khan, A, Sellars, W, Grater, W, Graham, MF, Pflanzer, J, Antonetti, A, Bailey, J, Hill, NO. The usefulness of transfer factor in asthma associated with frequent infections. Annals of Allergy 40(4):229-232 (1978).

For Additional Links: www.scholar.google.com keywords: Colostrum, Asthma

Anti-Microbial (Moldoveanu, Zina, et al, "Antibacterial Properties of Milk; IgA_ Peroxidase-Lactoferrin Interactions" Annals of N.Y. Academy of Science, (1983) Vol. 409, 848-850.

Conneely, OM. Anti-inflammatory activities of lactoferrin. Journal of the American College of Nutrition 20(Suppl.5):389S-395S (2001). Lactoferrin inhibits dermal inflammatory cytokine production and acts as a potent anti-inflammatory protein at local sites of inflammation, including the respiratory and gastrointestinal tracts.

Borody, TJ, et al. Tunnel vision in the bowel. Center for Digestive Diseases (2001). Review of irritable bowel syndrome, including ulcerative colitis and Crohn's disease, and its etiology, including infective agents such as Shigella and Campylobacter. Infections of the gut are difficult to treat because no antimicrobial therapy is available that is effective against Clostridia spores. Only bovine colostrum has proven clinical efficacy in eradicating intestinal pathogens, such as rotavirus, and may help control the infections seen in chronic disorders such as irritable bowel syndrome due to the number of biologically active components in colostrum. The growth factors in colostrum help heal intestinal erosions and ulcerations. It also contains anti-inflammatory factors and is nutrient rich. Colostrum may be used alone or in combination with other anti-inflammatory and/or immune substances. Future research should focus on identifying immune strategies, novel delivery systems and identification of the bioactives in colostrum.

Britigan, BE, et al. The role of lactoferrin as an anti-inflammatory molecule. Advances in Experimental Medicine and Biology 357:143-156 (1994). While the role of lactoferrin in providing non-specific immunity is well documented, it also plays a role in the anti-inflammatory response through its antioxidant effect.

Buescher, ES, McWilliams-Koeppen, P. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity. Pediatric Research 44(1):37-42 (1998). The ability of colostrum to modulate the inflammatory response is unique. One of the ways in which it does this is through TNF-a receptor proteins, which are found in colostrum. These bind to TNF-a, which inactivates the TNF-a. TNF-a is the activator of the entire inflammatory cascade, so by controlling its activity, colostrum controls the degree of the inflammatory response and can shut it off altogether.

Goldman, AS, et al. Anti-inflammatory properties of human milk. Acta Paediatrica Scandinavica 75(5):689-695 (1986). The major anti-inflammatory components found in human milk (and bovine colostrum) include anti-proteases, lactoferrin, lysozyme, secretory IgA, and a number of antioxidants, including cysteine, ascorbate, alpha-tocopherol and beta-carotene.

Kim, K. et al, "In Vitro and In Vivo Neutralizing Activity of Human Colostrum and Milk Against Purified Toxins A and B of Clostridium Difficle" Journal of Infectious Diseases (1984) Vol. 150 (1) 57-61.

McConnell, M.A.; Brooks, H.J.L.; Borissenko, M.B.; Buchan, G. A comparative study of immunoglobulin feels and anti-inflammatory activity in four milk products. Journal of Dairy Science. Publication forthcoming.

Murphey, DK, Buescher, ES. Human colostrum has anti-inflammatory activity in a rat subcutaneous air pouch model of inflammation. Pediatric Research 34(2):208-212 (1993). In an experimental animal model using subcutaneous air pouches in rats, colostrum showed significant anti-inflammatory activity.

Playford, RJ, et al. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44:653-658 (1999). Although non-steroidal anti-inflammatory drugs (NSAIDs) are very effective in controlling joint pain in arthritis, their use also causes significant, and sometimes fatal, gastrointestinal damage. Supplementation with colostrum, however, significantly reduced and healed injury caused by NSAIDs.

Playford, RJ, et al. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clinical Science 100:627-633 (2001). Another study by Dr. Playford on the ability of colostrum to prevent damage due to NSAID use. This study showed that colostrum also prevents an increase in gastrointestinal permeability due to NSAID use, whereas NSAID use alone without colostrum causes an increase in permeability.

Wada, N., et al, "Neutralizing Activity Against Clostridium Difficile Toxins in the Supernatant of Cultured Colostral Cells" Infectious Immunology (1980) Vol. 29, 545-550.

"Glycoproteins in bovine colostrum inhibit the attachment of the Helicobacter pylori bacteria that cause stomach ulcers. Colostrum contains significant amounts of interleukin-10, a strong inflammation inhibitory agent found significant in reducing inflammation in arthritic joints and injury areas," wrote Dr. Olle Hernell, from the University of Ulmea, Sweden, in Science magazine.

For Additional Links: www.scholar.google.com keywords: Colostrum, Anti-inflammatory

Ahmed, L, Islam, SN, Khan, MN, Huque, S, Ahsan, M. (2004) Antioxidant micronutrient profile (vitamin E, C, A, copper, zinc, iron) of colostrum: association with maternal characteristics. Journal of Tropical Pediatrics 50(6):357-8. Maternal characteristics had no influence on the profile of nutrient profile of antioxidants in colostrum.

Boldogh, I, et al. Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum. Journal of Molecular Neuroscience 20(2):125-134 (2003). Colostrinin down regulates lipid peroxidation, inhibits glutathione depletion and reduces intracellular levels of reactive oxygen species (ROS). This is one more way that colostrum demonstrates antioxidant activity.

Borissenko, M. Glutathione: A powerful anti-oxidant found in colostrum. NZMP August 2002. Both glutathione and its chemical predecessors are present in large quantities in colostrum. As glutathione is not absorbed directly, glutathione production in the body can only be accomplished by supplementation with its antecedents, cystine, glycine and glutamic acid, all of which are abundant in colostrum.

Buescher, ES, McIlheran, SM. Antioxidant properties of human colostrum. Pediatric Research 24(1):14-19 (1988). Colostrum reduces ferricytochrome C in polymorphonuclear leucocytes (PMNs) and also disrupts other metabolic and enzymatic activities of PMNs which are crucial in PMN respiratory burst mediation of acute inflammation, showing that colostrum is a powerful antioxidant.

Buescher, ES, McIlheran, SM. Colostral antioxidants: separation and characterization of two activities in human colostrum. Journal of Pediatric Gastroenterology and Nutrition 14(1):47-56 (1992). Colostrum interferes with the production of PMN respiratory burst products in two ways, ascorbate and uric acid.

Kurz, DJ, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. Journal of Cell Science 117:2417-2426 (2004). Oxidative stress due to the buildup of oxidization by-products has been linked to the onset of cell senescence in blood vessel lining cells by disrupting telomere integrity. Telomeres are the "tails" of the chromosomes, the length of which determine the number of cell divisions a cell can undergo before reaching its limit. Glutathione, a powerful natural antioxidant, is crucial in maintaining telomere integrity.

Satue-Gracia, MT, et al. Lactoferrin in infant formulas: effect on oxidation. Journal of Agriculture and Food Chemistry 48(10):4984-4990 (2000). Commercially modified infant formulas based on cow's milk have significantly less lactoferrin than whole milk, and soy formulas contain none, even though lactoferrin acts as an iron transporter protein. Adding lactoferrin to infant formulas results in the dual benefit of increased iron absorption and acts as an antioxidant and antimicrobial to extend the shelf life of the formulas.

Shigenaga, MK, et al. Oxidative damage and mitochondrial decay in aging. Proceedings of the National Academy of Sciences USA 91(23):10771-10778 (1994). The major source of oxidative damage are oxidants generated by mitochondria in the cells of the body. Mitochondrial function declines with age, including decreased membrane fluidity, proton leakage across the inner mitochondrial membrane, and decreases levels of cardiolipin, an important lipid which supports the functioning of proteins in the inner mitochondrial membrane.

Wakabayashi, H, et al. Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives. Bioscience, Biotechnology, Biochemistry 63(5):955-957 (1999). Lactoferrin also plays an important antioxidant role in colostrum by preventing lipid peroxidation.

For Additional Links: www.scholar.google.com keywords: Colostrum, Anti-oxidants

Antonio, J, et al. The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women. Nutrition 17(3):243-247 (2001). Actively training male and female athletes were given colostrum supplementation or placebo for a period of 8 weeks. Subjects receiving colostrum but not placebo showed an increase in lean body mass.

Berk, LS, et al. The effect of long endurance running on natural killer cells in marathoners. Medicine and Science in Sports and Exercise 22(2):207-212 (1990). A significant decrease in natural killer cell populations were seen in marathon runners following three hours of maximal exercise with full recovery of pre-exercise levels by 21 hours. This correlated with increases in cortisol levels during exercise.

Bricker, D.S. Colostrum: implications for accelerated recovery in damaged muscle and cartilage,prevention of some pathogenic disease. The American Chiropractor.pp. 4&5, November 1991.

Brinkworth, GD, et al. Effect of bovine colostrum supplementation on the composition of resistance trained and untrained limbs in healthy young men. European Journal of Applied Physiology 9(11):53-60 (2004). Either bovine colostrum or whey protein were given to young men who were either in training or not in training. Those in the training group who received colostrum showed a significantly greater increase in both upper arm circumference and cross-sectional area compared to those receiving whey, while those who were not in training showed no change.

Buckley, JD, et al. Effect of bovine colostrum on anaerobic exercise performance and plasma insulin-like growth factor I. Journal of Sports Science 21(7):577-588 (2003). Athletes in training were given either bovine colostrum or placebo for 8 weeks. Those receiving colostrum showed a significant increase in peak anaerobic power over placebo.

Buckley, J., et al. "Oral supplementation with bovine colostrum increases vertical jump performance." Presented at 4th Annual Congress of the European College of Sports Science, Rome 14-17 July, 1999.

Burke, ER. Colostrum as an Athletic Enhancer and Help for AIDS. Nutrition Science News May, 1996. While leaky gut is of concern to everyone, it is particularly so for athletes who need to utilize all the nutrients they take in and prevent infection when their immune systems are impaired following exercise. Many athletes suffer irritable bowel syndrome as a result of incomplete digestion of protein supplements. The role of colostrum-derived insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-ß) in healing leaky gut are explored.

Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D, Diabetes Branch, NIH, Bethesda, MD, Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology.Page 3, Comp Biochem Physiol B Biochem Mol Biol 1998 Sep; 121(1):19-26.

Clark J. (1996) Uses of creatine phosphate and creatine supplementation for the athlete. Scientific and Clinical Perspective (1996).

Crooks, C, et al. Bovine colostrum supplementation increases levels of s-IGA in distance runners: a study based on athletes in training for the 2002 Rotorua marathon. Unpublished research. Marathon runners in training were given bovine colostrum or placebo for 12 weeks in a double blind study. Those in the colostrum group showed significantly more secretory IgA (s-IgA) in their saliva than either the placebo group or sedentary controls. The colostrum group also reported a significantly lower rate of upper respiratory infections (URI) during this period.

Coombes JS, Conacher M, Austen SK, Marshall PA. "Dose effects of oral bovine colostrum on physical work capacity in cyclists."Med Sci Sports Exerc. 2002 Jul;34(7):1184-8. Related Articles, Links, Dose effects of oral bovine colostrum on physical work capacity in cyclists. School of Human Movement Studies, University of Queensland, St Lucia, Australia.

Liu JL, LeRoith D, Clinical Endocrinology Branch, NIDDKD, NIH, Bethesda, MD, Insulin-like growth factor I is essential for post-natal growth in response to growth hormone. Endocrinology 1999 Nov; 140(11):5178-84.

Hwa V, Oh Y, Rosenfeld RG, Dept. of Pediatrics, Oregon Health Sciences University, Portland, OR, The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev 1999 Dec; 20(6):761-87.

Hofman, Z, et al. The effect of bovine colostrum supplementation on exercise performance in elite field hockey players. International Journal of Sports Nutrition and Exercise Metabolism 12(4):461-469 (2002). Colostrum supplementation in elite field hockey players, both male and female, resulted in improved sprint performance over placebo.

Kasemkijwattana, C, et al. Use of growth factors to improve muscle healing after strain injury. Clinical Orthopedics 370:272-285 (2000). Muscle injuries, such as strains, are common in athletes. The use of growth factors, such as IGF-1, in treating such injuries is explored.

Kuipers, H, et al. Effects of oral bovine colostrum supplementation on serum insulin-like growth factor-I levels. Nutrition 18(7-8):165-172 (2002). A study for the International Olympic Committee showed no increase in blood IGF-1 or IGF-bp3 levels after 4 weeks time.

Liang, L, et al. [Effect of cytokines on repair of tendon injury] Zhongguo Xiufu Chongjian Waike Zazhi (Chinese) 14(5):283-285 (2000). Cytokines, such as the growth factors, can accelerate tendon repair.

Mero, A, et al. IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training. Journal of Applied Physiology 93(2):732-739 (2002). Colostrum supplementation increases levels of IGF-1 and IgA in training athletes, but the IGF-1 in the colostrum is not absorbed intact.

Nieman, DC, et al. Complement and immunoglobulin levels in athletes and sedentary controls. International Journal of Sports Medicine 10(2):124-128 (1989). Blood levels of complements C3 and C4 but not immunoglobulins decreased during periods of rest, graded maximal exercise and recovery in marathon runners.

Nieman, DC, et al. Effects of long-endurance running on immune system parameters and lymphocyte function in experienced marathoners. International Journal of Sports Medicine 10(5):317-323 (1989). Marathon runners experience a disruption of normal immune function after running long distances, a condition which returns to normal levels following 21 hours of recovery.

Molloy, T, et al. The roles of growth factors in tendon and ligament healing. Sports Medicine 33(5):381-394 (2003). The roles of five different growth factors, IGF-1, TGF-ß, vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF), in healing tendon and ligament injuries is explored. Each plays a different but vital role in the process.

Mero A, et al. (1997) Effects of bovine colostrum supplementation on serum IGF-1, IgG, hormone, and saliva IgA during training. Journal of Applied Physiology. 83:1144-1151.

Sato, K, et al. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle & Nerve 28(3):355-372 (2003). IGF-1 can improve muscle regeneration in injured muscle.

Spagnoli A, Rosenfeld RG, Dept. of Pediatrics, Oregon Health Sciences University, Portland, OR, The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors. Endocrinol Metab Clin North Am 1996 Sep; (3):615-31.

Sparling PB, Nieman DC, O'Connor PJ. (1993) Selected scientific aspects of marathon racing: an update on fluid replacement, immune function, psychological factors and the gender difference. Sports Medicine. 15:116-132.

Sparling, PB, et al. Selected scientific aspects of marathon racing. An update on fluid replacement, immune function, psychological factors and the gender difference. Sports Medicine 15(2):116-132 (1993). Negative changes to the immune system during long distance running increase the chances of upper respiratory infections in these athletes for a period following exercise. Proper nutrition, adequate rest and appropriate recover between workouts as well as other measures can lessen the risk.

Wu, A.H. & Perryman, M.B. "Clinical applications of muscle enzymes and proteins." Curr Opin Rheumatol, 1992;4(6):815-820.

Zimecki, M, et al. Effect of a proline-rich polypeptide (PRP) on the development of hemolytic anemia and survival of New Zealand black (NZB) mice. Archivum Immunologiae et Therapiae Experimentalis 39(5-6):461-467 (1991). Colostrinin (PRP) increased survival in mice susceptible to hemolytic anemia, an autoimmune disease. It is hypothesized the colostrinin induces suppressor cells which slow development of the disease. This suggests that colostrinin may have therapeutic value in treating autoimmune diseases.

For Additional Links: www.scholar.google.com keywords: Colostrum, Althetic Performance

Bitzan, M.M.; Gold, B.D.; Philpott, D.J.; Huesca, M.; Sherman, P.M.; Karch, H.; Lissner, R.; Lingwood, C.A.; Karmali, M.A.; Inhibition of Helicobacter pylori and Helicobactor mustelae binding to lipid receptors by bovine colostrum. The Journal of Infectious Diseases. 177:955-961, April 1998.

Bitzan, MM, et al. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. Journal of Infectious Disease 177(4):955-961 (1998). H. pylori and H. mustelae (a gastric pathogen of ferrets) are both bound by lipid receptors (phosphatidylethanolamine, gangliotetraosylceramide and gangliotriaosyl-ceramide) in the gut, allowing them to carry out their pathogenic activities. Bovine colostrum, however, was shown to prevent binding of the pathogens to these lipid receptors even though there was no detectable anti-H. pylori antibody activity in the colostrum.

Bolke E, Jehle PM, Hausmann F, Daubler A, Wiedeck H, Steinbach G, Storck M, Orth K., Shock. 2002 Jan;17(1):9-12. Related Articles, Links, Preoperative oral application of immunoglobulin-enriched colostrum milk and mediator response during abdominal surgery. Department of Surgery, University of Ulm, Germany.

Butler, J. E. Immunoglobulins of the Mammary Secretions. Chapter Five. in: Lactation: A Comprehensive Treatise. Vol. 3. Eds. B. L. Larson and V. R. Smith. pp. 217-252. Academic Press. New York. 1974.

Casswall, TH, et al. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scandinavian Journal of Gastroenterology 37(12):1380-1385 (2002). Bovine colostrum with high titers against H. pylori was given to H. pylori infected mice. Comparison of treated mice with control mice showed a 50-66% cure rate for H. pylori infection in treated mice. Binding studies also showed that the colostrum prevented binding of the H. pylori.

Christopher-Hennings, J., et al., lmmunocompromise in gnotobiotic pigs induced by verotoxin-producing Escherichia coli (Olll:NM). Infect. Immun. 1993. 61: p. 2304-2308.

da Costa, RS, et al. Characterization of iron, copper and zinc levels in the colostrum of mothers of term and pre-term infants before and after pasteurization. International Journal of Food Science and Nutrition 54(2):111-117 (2003). Milk samples were collected from mothers from day 1 to day 7 postpartum. Milk that was pasteurized showed some diminution of zinc, copper and iron levels, but not to a significant degree. Sufficient levels remained in the pasteurized milk to supply the needs of the new-born infants.

Doyle, P. S. Anti-Cryptosporiduim antibodies inhibit infectivity in vitro and in 9 vivo. Infection and Immunity 61(10):4079-4084. Oct. 1993.

Ellison, RT III, Giehl, TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. Journal of Clinical Investigation 88(4):1080-1091 (1991). Lactoferrin and lysozyme act together to kill gram-negative bacteria, such as Vibrio cholerae (cholera), Salmonella typhimurium (food poisoning) and Eschericia coli. The lactoferrin attaches to and destroys the cell wall of the bacteria, allowing the lysozyme to enter and lyse (burst) the organisms.

Fayer R, Perryman LE, Riggs MW.J Parasitol. 1989 Feb;75(1):151-3. Related Articles, Links, Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge. Zoonotic Diseases Laboratory, United States Department of Agriculture, Beltsville, Maryland 20705.

Flanigan T, Marshall R, Redman D, Kaetzel C, Ungar B. J Protozool. 1991 Nov-Dec;38(6):225S-227S. Related Articles, Links, In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory. Department of Medicine, University Hospitals, Case Western Reserve University, Cleveland, OH.

Funatogawa K, Ide T, Kirikae F, Saruta K, Nakano M, Kirikae T. Microbiol Immunol. 2002;46(11):761-6. Related Articles, Links, Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. Southern Direct Meat Products Inspection Office, Tochigi, Tochigi 328-0033, Japan.

Holloway, NM, et al. Serum immunoglobulin G concentrations in calves fed fresh and frozen colostrum. Journal of the American Veterinary Medicine Association 219(3):357-359 (2001). No significant difference was found between the IgG concentrations of fresh bovine colostrum and frozen and thawed bovine colostrum.

Ho, P.C., and Lawton, J.W.M. Human colostral cells: Phagocytosis and killing of E. Coli and C. Albicans. The Journal of Pediatrics. Vol. 93, No. 6, pp. 910-915.

Kim, K., et al., In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. T. Infect. Dis. 1985. 150: p. 57-61.

Gopal, PK, and Gill, HS. Oligosaccharides and glycoconjugates in bovine milk and colostrum. British Journal of Nutrition 84(Suppl.1):S69-S74 (2000). Another way colostrum helps protect against infections is through the oligosaccharides and glycoconjugates it contains. These are complex sugars which compete for binding sites in the GI tract with pathogens.

Graczyk TK, Cranfield MR, Bostwick EF., J Parasitol. 2000 Jun;86(3):631-2. Related Articles, Links, Successful hyperimmune bovine colostrum treatment of Savanna monitors (Varanus exanthematicus) infected with Cryptosporidium sp. Department of Molecular Microbiology and Immunology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.

Huppertz HI, Rutkowski S, Busch DH, Eisebit R, Lissner R, Karch H., J Pediatr Gastroenterol Nutr. 1999 Oct;29(4):452-6. Related Articles, Links, Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin-producing E. Coli, and E. coli expressing intimin and hemolysin. Children's Hospital, The University of Wurzburg, Germany.

Korhonen, H, et al. Milk immunoglobulins and complement factors. British Journal of Nutrition 84(Suppl.1):S75-S80 (2000). Bovine colostrum contains three main classes of immunoglobulin IgG (IgG1 75% and IgG2), IgM and IgA, plus hemolytic and bactericidal complement. Complement is a complex group of proteins which act in concert with antibodies to inactivate and/or kill pathogens.

Korhonen, H, et al. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. Journal of Applied Bacteriology 78(6):655-662 (1995). Helicobacter pylori is a major cause of gastritis and ulcers in humans. Serum and colostrum from non-immunized Friesian cows were found to be highly bactericidal against H. pylori. Post-colostral milk did not show any bactericidal effect against H. pylori.

Lilius, EM, Marnila, P. The role of colostral antibodies in prevention of microbial infections. Current Opinion in Infectious Diseases 14(3): 295-300 (2001). Colostrum offers passive protection against a variety of microbial pathogens in the form of specific immunoglobulin A, G and M antibodies. It is especially effective in the prevention of various gastroenteric infections.

Lilius EM, Marnila P. Curr Opin Infect Dis. 2001 Jun;14(3):295-300. Related Articles, Links, The role of colostral antibodies in prevention of microbial infections. Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland.

Masson, PL, et al. An iron-binding protein common to many external secretions. Clinica Chemica Acta 14:735 (1966). Lactoferrin inhibits the growth of siderophilic (iron-loving) bacteria and Candida albicans.

Majumdar, A. S., et al., Protective properties of anti-cholera antibodies in human colostrum. Infect. Immun. 1982. 36:p. 962965.

McClead, R., et al., Resistance of bovine anti-cholera toxin IgG to in vitro and in vivo proteolysis. Pedia. Res. 1982.6: p. 227-231.

McClead RE Jr, Butler T, Rabbani GH. Am J Med. 1988 Dec;85(6):811-6. Related Articles, Links, Orally administered bovine colostral anti-cholera toxin antibodies: results of two clinical trials. Department of Pediatrics, Ohio State University 43205.

Morris, J. A., et al., Passive protection of lambs against enteropathogenic Escherichia coli: Role of antibodies in serum and colostrum. T. Med. Microbiol.1980. 13: p. 265-271.

McClead RE, Gregory SA. Infect Immun. 1984 May;44(2):474-8. Related Articles, Links, Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis.

Michalek SM, McGhee JR. (1977) Effective immunity to dental caries: passive transfer to rats to antibodies to streptococcus mutans elicits protection. Infection and Immunity. 17:644-650.

Opdebeeck JP, Norcross NL. Am J Vet Res. 1985 Jul;46(7):1561-4. Related Articles, Links, Antibodies in bovine serum and lacteal secretions to capsular antigens of Staphylococcus aureus.

Ogra, PL, et al. Colostrum derived immunity and maternal neonatal interaction. Annals of the New York Academy of Sciences 409: 82-92 (1983). Peyer's patches are found throughout the intestinal tract, and groups of similar immunoactive cells are found in the bronchial mucosa. Both the intestinal and bronchial immunoactive cell groups respond to allergens, antigens and pathogens by neutralizing or destroying them. In newborns, these special cell groups are not immediately operative but protection is provided by a variety of immune factors from the mother's colostrum. Antibodies found in colostrum protect against Eschericia coli, Salmonella, Shigella, Vibrio cholera, Bacteriodes fragilis, Streptococcus pneumoniae, Bordtella pertussis, Clostridium diphtheria, Clostridium tetani, Streptococcus mutans and Candida albicans.

Paulsson, MA, et al. Thermal behavior of bovine lactoferrin in water and its relation to bacterial interaction and antibacterial activity. Journal of Dairy Science 76(12):3711-3720 (1993). Lactoferrin which was either unheated or pasteurized showed similar activity, while lactoferrin exposed to UHT treatment decreased its ability to bind to bacterial species and destroyed its ability to inhibit bacterial growth.

Spik, G., et al., Bacteriostasis of a milk-sensitive strain of E. coli immunoglobulins and iron-binding proteins associated with colostrum. Immunology 1981. 35: p. 663-670.

Seifert J, Molkewehrum M, Oesser S, Nebermann L, Schulze C. Eur Surg Res. 2002 Jan-Apr;34(1-2):68-72. Related Articles, Links, Endotoxin inactivation by enterally applied colostrum of different composition. Surgical Research, Department of Surgery and Thoracic Surgery, Kiel, Germany.

Stephan W, Dichtelmuller H, Lissner R. J Clin Chem Clin Biochem. 1990 Jan;28(1):19-23. Related Articles, Links, Antibodies from colostrum in oral immunotherapy. Biotest Pharma GmbH, Forschungsabteilung, Frankfurt.

Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Am J Trop Med Hyg. 1992 Sep;47(3):276-83. Related Articles, Links, Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Department of Medicine, University of Maryland School of Medicine, Baltimore.

Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM. N Engl J Med. 1988 May 12;318(19):1240-3. Related Articles, Links, Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. Department of Medicine, University of Maryland School of Medicine, Baltimore.

Takakura N. et al."Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model."J Med Microbiol. 2004 Jun;53(Pt 6):495-500.

Ushijima H, Dairaku M, Mukoyama A. Kansenshogaku Zasshi. 1991 Jan;65(1):54-60. Related Articles, Links,[Bacteriostatic activity of bovine colostrum][Article in Japanese],Department of Enteroviruses, National Institute of Health.

Wada, T, et al. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scandinavian Journal of Gastroenterology 34(3):238-243 (1999). Mice infected with H. pylori were given a daily dose of bovine lactoferrin for 2-4 weeks. Their intestines were then examined for bacterial content. Numbers of H. pylori were reduced to 10% of pre-lactoferrin levels and greatly decreased the numbers of H. pylori bound to the intestinal wall. Serum antibody titer to H. pylori were reduced to practically zero, indicating that the immune response of the host was no longer recognizing H. pylori infection. Therefore it was deduced that lactoferrin has a direct antibacterial effect on H. pylori infection and prevents binding of the pathogen to the intestinal lining.

Wada, N., et al., Neutralizing activity against Clostridium difficile toxins in the supernatants of cultured colostral cells. Infect. Immun.. 1980.29: p. 545-550.

Watzl, B., et al., Enhancement of resistance to Cryptosporidium parvum by pooled bovine colostrum during murine retroviral infection. Am. T. Trop. Med. Hyg. 1993. 48(4): p. 519-523.

For Additional Links: www.scholar.google.com keywords: Colostrum, Anti-bacterial

Gross, Neil; Carey, John; Hamilton, Joan. "Quiet Strides in the War on Cancer" Business Week. February 6:150, 1995.

Lidbeck, A.; Allinger, U. G.; Orrhage, K. M.; Ottova, L.; Brismar, B.; Gustafsson, J. A.; Rafter, J.; Nord, C. E. "Impact of Lactobacillus Acidophilus Supplements on the Fecal Microflora and Soluble Fecal Bile Acids in Colon Cancer Patients," Microbial Ecology in Health and Disease. 4:81-8, 1991.

Lidbeck, A.; Nord, C. E.; Gustafsson, J. A.; Rafter, J. "Lactobacilli, Anticarcinogenic Activities and Human Intestinal Microflora," Eur J Cancer Prev. 1:341-353, 1992.

Shahani, K. et al, Antitumor activity of fermented colostrum and milk 01-May-83 - Investigated the effect of feeding fresh colostrum and colostrum cultured with either L. acidophilus, L. bulgaricus or yoghurt starter on the proliferation of ascites tumor cells.

Parodi, PW. Cows' milk fat components as potential anticarcinogenic agents. Journal of Nutrition 127(6):1055-1060 (1997). Including dairy products in the diet has been shown to lessen the chance of developing cancer. One of the ways dairy products accomplish this is through the anticarcinogenic properties of several milk fats, including conjugated linoleic acid (CLA), sphingomyelin, butyric acid and ether lipids. Cows also have the ability to absorb anticarcinogenic compounds, such as beta-carotene, beta-ionone and gossypol, from their feed and include them in their milk.

Parodi, PW. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci. 1999 Jun;82(6):1339-49.. CLA in even small amounts has a potent anticarcinogenic effect, as does sphingomyelin. Other components of milk with anticarcinogenic activity include butyric acid, ether lipids, beta-carotene and vitamins A and D.

Pizza, G, et al. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy 9(1-3):123-132 (1996). Transfer factor (PRPs) increased the survival rate of stage D3 prostate cancer patients.

See, D, et al. Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunological Investigations 31(2):137-153 (2002). PRPs are known to increase the production of both TNF-alpha and NK cell activity. This treatment strategy has shown promise in the treatment of terminal cancers.

For Additional Links: www.scholar.google.com keywords: Colostrum, Cancer

Blach-Olszewska, Z, Janusz, M. Stimulatory effect of ovine colostrinine (a proline-rich polypeptide) on interferons and tumor necrosis factor product by murine resident peritoneal cells. Archivum Immunologiae et Therapie Experimentalis (Warsaw) 45(1):43-47 (1997). Colostrinin stimulates the production of tumor necrosis factor-alpha (TNF-a) and interferon-beta (INF-ß), both important cytokines in the inflammatory response.

Bocci, V, et al. What is the role of cytokines in human colostrum? Journal of Biologic Regulatory and Homeostatic Agents 5(4):121-124 (1991). The cytokines present in colostrum, such as TNF-a, interferon-g, IL-1 and IL-6, have an immunostimulatory effect. This could be significant for aged people or others with immunodeficiency.

Bessler, H., et al. Human colostrum stimulates cytokine production. Biology of the Neonate 69(6):376-382 (1996). Colostrum has also been shown to stimulate the production of certain cytokines, IL-1, IL-3 and IL-6, in peripheral white blood cells (monocytes).

Bogdan, C, Nathan, C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Annals of the New York Academy of Science 685:713-739 (1993). Certain cytokines found in colostrum, TGF-ß, IL-4 and IL-10, have a modulatory effect on macrophages, either stimulating or deactivating them as conditions dictate.

Feldmann, M, et al. Cytokines in autoimmune disorders. International Review of Immunology 17(1-4)217-228 (1998). Cytokines are important protein mediators of immunity, inflammation, cell proliferation, differentiation, fibrosis, and so forth, in other words, all the major biological processes which underlie autoimmune disorders. Modulating the effects of these cytokines, particularly TNF-a, can result in amelioration of the symptoms of the disorders.

Hagiwara, K, et al. Detection of cytokines in bovine colostrum. Veterinary Immunology and Immunopathology 76:183-190 (2000).

Inglot, A.D., et al. "Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes." Arch Immunol Ther Exp (Wasz), 1996;44(4):215-224.

Zoltan P. Rona, M.D., M.Sc., Bovine Colostrum Emerges as Immunity Modulator, American Journal of Natural Medicine, March 1998.

For Additional Links: www.scholar.google.com keywords: Colostrum, Cytokines

"A New Way to Fight Diabetes" Newsweek. November 15, 1993. Dohm, G. L.; Elton, C. W.; Raju, M. S.; Mooney, N. D.; DiMarchi, R.; Pories, W. J.; Flickinger,

Aranda P. "Insulin in bovine colostrum and milk: evolution throughout lactation and binding to caseins." J Dairy Sci. 1991 Dec;74(12):4320-5..

Binz, K. et al. Repopulation of The Atrophied Thymus in Diabetic Rats by Insulin-like Grown Factor I. Proc. Natl. Acad. Sci. USA. 87(10):3690-3694. May 1990.

Chen, W, et al. Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 145(2):627-638 (2004). IGF-1 regulates beta cell growth, survival and metabolism in the pancreas and protects them against development of type 1 diabetes. Using IGF-1 combined with IGF-binding protein (IGF-bp) significantly increases the efficacy of IGF-1 treatment by extending its half-life in the body.

Dohm, Elton, et al. IgF-1 stimulated glucose transport. Diabetes, Sept. 30, 1990, pp. 1028-32.

Dohm. G.; et al. "IGF-1 Stimulated Glucose Transport in Human Skeletal Muscle and IGF-I Resistance in Obesity and NIDDM," Diabetes. 39(9):1028-1032, 1990.

McDevitt, H. "Characteristics of Autoimmunity in Type 1 Diabetes and Type 1.5 Overlap With Type 2 Diabetes" Section I: Aspects of PathophysiologyDiabetes 54:S4-S10, 2005. Department of Medicine, and Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.

Pennisi. "Immune Therapy Stems Diabetes Progress" Science News. 145:37, January 15, 1995.

Tuomi, T. "Type 1 and Type 2 Diabetes, What Do They Have in Common?" Section I: Aspects of Pathophysiology Diabetes 54:S40-S45, 2005. From the Department of Internal Medicine/Diabetology, Helsinki University Central Hospital; the Institute for Diabetes Genetics, Folkhalsan Research Center, Helsinki, Finland; and the Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland.

Stone, T. "Components in Colostrum Balance Blood Sugar Levels and Reduce Insulin Requirements" Colostrum Can Stabilize Blood Sugar, 1993

Thivolet, C. Use of IGF-1 or analogues thereof in the prevention of diabetes. US Patent #6,342,227 (2002). IGF-1 or an analogue can delay the clinical onset of diabetes when administered at the first sign of the disease. Additionally, IGF-1 or analogue given to patients at high risk for developing the disease significantly reduces the likelihood of developing diabetes.

Vaarla, O. The gut immune system and type 1 diabetes. Annals of the New York Academy of Science 958:39-46 (2002). There is increasing evidence that the gut immune system is important in the development of type 1 (autoimmune) diabetes. One of the causes of type diabetes in children may be too early introduction of cow’s milk to the diet in infants, which causes an autoimmune response to insulin.

For Additional Links: www.scholar.google.com keywords: Colostrum, Diabetes

Bitzan MM, Gold BD, Philpott DJ, et al. (1998). Inhibition of Helicobacter pylori and Helicobactor mustelae binding to lipid receptors by bovine colostrum. The Journal of Infectious Diseases. 177:955-961.

Blum J, Hadorn U, Sallmann H, and Schuep W. (1997) Delaying colostrum intake by one day impairs plasma lipid, essential fatty acid, carotene, retinal and a-tocopherol status in neonatal calves. American Society for Nutritional Sciences.

Cavalli-Sforza LT, Strata A. (1987). Double-blind study on the tolerance of four types of milk in lactose malabsorbers. Human Nutrition: Clinical Nutrition. 40C:19-30.

Cenacchi T, Baggio C, and Palin E. (1987). Human tolerability of oral phosphatidylserine assessed through laboratory examinations. Clinical Trials Journal. 24.

Efigenia M, Povoa B, Moraes-Santos T. (1997). Effect of heat treatment on the nutritional quality of milk proteins. International Dairy Journal. 7:609-612.

Fishbein L, Kaplan M, Gough M. (1988) Fructooligosaccharides: A review. Vat Hum Toxicology. 30:104-108.

Ghidini A, Hicks C, Lapinski RH, Lockwood CJ. (1997) Morbidity in the preterm infant with mature lung indicies. American Journal of Perinatology. 14:75-78.

Jensen R. (1998) Human milk lipids as a model for infant formulas. Lipid Technology. 34(12):1243-71

Joseph M. and Flesch A. (1998) Research shows colostrum to be one of nature's most potent, broad-spectrum substances. Chiropractic Journal.

Jochims K, Kaup FJ, Drommer W. (1994) Immunoelectron microscopical demonstration of the absorption of colostral IgG by small intestinal enterocytes in newborn rats. Research in Veterinary Science. 57:146-151.

Klagsbrun M. (1978) Human milk stimulates DNA synthesis and cellular proliferation in cultured fibroblasts. Proceedings of the National Academy of Sciences, USA. 75:5057-5061.

Kume S, Tanabe S. (1993). Effect of parity on colostral mineral concentrations of holstein cows and value of colostrum as a mineral source for newborn calves. Journal of Dairy Science. 76:1654-1660.

Le Dividich J, Herpin P, Paul E, Strullu F. (1997). Effect of fat content of colostrum on voluntary colostrum intake and fat utilization in newborn pigs. Journal of Animal Science. 75:707-713.

Li-Chan E, Kummer A, Lasso J, Kitts D, Nakai S. (1995) Stability of bovine immunoglobulin to thermal treatment and processing. Food Research International. 28:9-16.

McConnell MA, Brooks HJL, Borissenko MB, Buchan GA. A comparative study of immunoglobulin levels and anti-inflammatory activity in four milk products. Journal of Dairy Science. Publication forthcoming.

Nitsch A, and Nitsch F. (1998). The clinical use of bovine colostrum. Journal of Orthomolecular Medicine. 13.

Wit JN. (1998). Nutritional and functional characteristics of whey proteins in food products. Journal of Dairy Science. 81:597-608.

Walker WA. (1999) What is the role of nucleotides and polyamines in breast milk? Acta Peadiatrica. 88:1313-1315.

Warny M, Fatima A, Bostwick E, et al. (1998) Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralizing activity after passage through the human stomach and small intestine. Gut. 44(2):212-7.

Wieczorek Z, Zimecki M, Janusz M, Staroscik K, Lisowski J. (1979) Proline-rich polypeptide from ovine colostrum: its effect on skin permeability and on the immune system. Immunology. 36:879-881.

Yamamoto A, Wada O, Suzuki H. (1987) Purification and properties of biologically active chromium complex from bovine colostrum. American Institute of Nutrition. 118(1):39-45.

Zhang T, Iguchi K, Mochizzuki T, Hoshino M, Yanaihara C, Yanaihara N. (1990) Gonadotropin-releasing hormone-associated peptide immunoreactivity in bovine colostrum. Society for Experimental Biology and Medicine. 194(3):270-3.

Al-Mashikhi SA, Li-Chan E, Nakai S. Separation of immunoglobulins and lactoferrin from cheese whey by chelating chromatography. J Dairy Sci 1988; 71: 1747-1755.

Andersson I, Ardö Y, Christiansson A, Johnsson G, Lindmark Månsson H, Nyberg L, Pettersson HE, Svensson U. Mjölkråvaran. Rapport FoU Mjölkråvara 1998; pp. 70-78.

Baick SC, Yu JH. Separation of immunoglobulin from Holstein colostrum and its immunological response. Foods Biotechnol 1995; 4: 117-121.

Baranova VS, Pustovoi VK. Fatty acid spectrum of colostrum and milk of Ayrshire cows during lactation. S Kh Zhivotn 1983; 37. In: Chem Abstr 1984; 100: p 108119

Bitman J, Wood DL. Changes in milk fat phospholipids during lactation. J Dairy Sci 1990; 73:1208-1216.

Brussow H, Hilpert H, Walther I, Sidoti J, Mietens C, Bachmann P. Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol 1987; 25(6):982-986.

Buckley J, Abbott M, Martin S, Brinkworth G, Whyte P. Effect on an oral bovine colostrum supplement (intact™) on running performance. Abstract from: 1998 Australian conference of science and medicine in sport, Adelaide, South Australia, October 1998.

Carlsson J. Spädkalven - vikten av en bra start. Svensk Husdjursskötsel AB; Djurhälso- och utfodringskonferens 1997, Projektet ”Råmjölkens kvalitet hos svenska mjölkkor och dessa betydelse för kalvimmunitet och hälsa”.

Chen JP, Wang CH. Microfiltration affinity purification of lactoferrin and immunoglobulin G from cheese whey. J Food Sci 1991; 56: 701-706.

Collard A, Pivont P, Portetelle D, Gregoire R, Burny A, Antoine H. Isolation and purification of bovine immunoglobulins: use of Sephacryl S-300 filtration avoids protein precipitation steps. Ann Rech Vét 1984; 15:497-501.

Collier RJ, Miller MA, Hildebrandt JR, Torkelson AR, White TC, Madsen KS, Vicini JL, Eppard PJ, Lanza GM. Factors affecting insulin-like growth factor-1 concentration in bovine milk. J Dairy Sci 1991; 74:2905-2911.

Collins AM, Roberton DM, Hosking CS, Flannery GR. Bovine milk, including pasteurized milk, contains antibodies directed against allergens of clinical importance to man. Int Arch Allergy Appl Immunol 1991(1992); 96:362-367.

Danielpour D, Sporn MB. Differential inhibition of transforming growth factor ?1 and ?2 activity by ?2-macroglobulin. J Biol Chem 1990; 265:6973-6977.

Daopin S, Piez KA, Yasushi O, Davies DR. Crystal structure of transforming growth factor-?2: An unusual fold for the superfamily. Sci 1992; 257:369-373.

Davidson GP. Passive protection against diarrheal disease. Invited review. J Ped Gastroenterol Nutr 1996; 23:207-212.

Devery-Pocius JE, Larson BL. Age and previous lactations as factors in the amount of bovine colostral immunoglobulins. J Dairy Sci 1983; 66: 221-226.

Dominguez E, Perez MD, Calvo M. Effect of heat treatment on the antigen-binding activity of anti-peroxidase immunoglobulins in bovine colostrum. J Dairy Sci 1997; 80: 3182-3187.

Ebina T, Sato A, Umezu K, Ishida N, Ohyama S, Oizumi A, Aikawa K, Katagiri S, Katsushima N, Imai N, Kitaoka S, Suzuki H, Konno T. Prevention of rotavirus infection by oral administration of cow colostrum containing anti-human rotavirus antibody. Med Microbiol Immunol 1985; 174: 177-185.

Einspanier R, Schams D. Changes in concentrations of insulin-like growth factor 1, insulin and growth hormone in bovine mammary gland secretion ante and post partum. J Dairy Res 1991; 58:171-178.

Emmons DB, Elliot JA and Beckett DC. Agglutination of starter bacteria, sludge formation and slow acid development in cottage cheese manufacture. J Dairy Sci 1963; 46: 600 (Abstr).

Emmons DB, Elliot JA and Beckett DC Sensitive test for lactic streptococcal agglutinins. J Dairy Sci 1965; 48: 1245-1249

Emmons DB, Elliot JA and Beckett DC. Effect of lactic-streptococcal agglutininsin milk on curd formation and manufacture of cottage cheese. J. Dairy Sci 1966; 49: 1357-1361.

Facon M, Scura BJ, Nakay S. Potential for immunological supplementation of foods. Food Agric Immunol 1993; 5:85-91.

Fleenor WA, Stott GH. Hydrometer test for estimation of immunoglobulin concentration in bovine colostrum. J Dairy Sci 1980; 63: 973-977.

Fleenor WA, Stott GH. Single radial immunodiffusion analysis for quantitation of colostral immunoglobulin concentration. J. Dairy Sci 1981; 64: 740-747.

Foley JA, Otterby DE. Availability, storage, treatment, composition, and feeding value of surplus colostrum: a review. J Dairy Sci 1978; 61:1033-1060.

Francis GL, Upton FM, Ballard FJ, McNell KA, Wallace JC. Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. Biochem J 1988; 251:95-103.

Fredholm BB, Heldin CH. Tillväxtfaktorer - mekanismerna klarnar. Läkartidningen 1995; 92:1459-1467.

Fukumoto LR, Skura BJ, Nakai S. Stability of membrane-sterilized bovine immunoglobulins aseptically added to UHT milk. J Food Sci 1994; 59(4):757-759.

Ginjala V, Pakkanen R. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor 1 (IGF-1) in bovine colostrum samples. J Immunoassay 1998; 19:195-207.

Hammarström L, Gardulf A, Hammarström V, Janson A, Lindberg K, Smith CIE. Systemic and topical immunoglobulin treatment in immunocompromised patients. Immunol Reviews 1994; 139: 43-70.

Hanson LÅ. Infektionsförsvaret in Immunologi, part 2, by Hanson LÅ and Wigzell H. 1988; p. 25.

Hekmati M, Niroumand K. Comparative study and variations of colostral milk components in foreign and native breeds in Iran. Milchwissenschaft 1978; 33:24-27.

Heldin CH, Miyazono K. Transforming growth factor-?, a promising candidate for clinical use. Läkartidningen 1995; 92:1569-1572.

Hilpert H. A process for the production of a protein concentrate containing immunological factor of lactic origin. Patent. Application No. 11106/78. 1978.

Hoch GJ. Whey to go. Food Process 1997; 58:51-52.

Husu J, Syväoja E-L, Ahola-Luttila H, Kalsta H, Sivelä S, Kosunen TU. Production of hyperimmune bovine colostrum against Campylobacter jejuni. J Appl Bact 1993; 74:564-569.

Jalonen H, Luopa J, Aalto J. Nutritional drink. Patent. Int Publ No. WO 95/10192. 1995.

Jin Y, Cox DA, Knecht R, Raschdorf F, Cerletti N. Separation, purification, and sequence identification of TGF-?1 and TGF-?2 from bovine milk. J Prot Chem 1991; 10: 565-575.

Kanamaru Y, Ozeki M, Nagaoka S, Kuzuya Y, Niki R. Ultrafiltration and gel filtration methods for separation of immunoglobulins with secretory component from bovine milk. Milchwissenschaft 1993; 48: 247-251.

Kehrl JH. Transforming growth factor-?: an important mediator immunoregulation. Int J Cell Cloning 1991; 9:438-450.

Kim H, Li-Chan E.C.Y. Separation of immunoglobulin G from Cheddar cheese whey by avidin-biotinylated IgY chromatography. J Food Sci 1998; 63: 429-434.

Kim PH, Kagnoff MF. Transforming growth factor-?1 is a costimulator for IgA production. J Immunol 1990; 144: 3411-3416.

Kingsley DM. The TGF-? superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Develop 1994; 8:133-146.

Knight KL, Suter M, Becker RS. Genetic engineering of bovine Ig. Construction and caracterization of hapten-binding bovine/murine chimeric IgE, IgA, IgG1, IgG2, and IgG3 molecules. J Immunol 1988; 140: 3654-3659.

Konecny P, Brown RJ, Scouten WH. Chromatographic purification of immunoglobulin G from bovine milk whey. J Chromatogr A 1994; 673(1):45-53.

Korhonen H, Pihlanto-Leppälä A, Rantamäki P, Tupasela T. The functional and biological properties of whey proteins: prospects of the development of functional foods. Agric Food Sci Finland 1998; 7:283-296.

Korhonen H, Rantamäki P, Rokka T. Functionality of bovine colostral whey protein hydrolysates. In: Abstracts of the 1997 International conference on food science and technology, Las Vegas, USA 1997; p.19.

Korhonen H, Syväoja E-L, Ahola-Luttila H, Sivelä S, Kopola S, Husu J, Kosunen TU. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995; 78:655-662.

Kulkarni PR, Pimpale NV. Buffalo colostrum gels. J Dairy Res 1988; 55:117-120.

Kulkarni PR, Pimpale NV. Colostrum-a review. Indian J Dairy Sci 1989; 42: 216-224.

Kummer A, Kitts DD, Li-Chan E, Losso JN, Skura BJ, Nakai S. Quantification of bovine IgG in milk using enzyme-linked immunosorbent assay. Food Agric Immunol 1992; 4:93-102.

Larson BL. Immunoglobulins of the mammary secretions. In: Fox PF (Editor) Advanced Dairy Chemistry-1: Proteins. Elsevier, London, New York 1992; pp 231-254.

Lee MH, Shon JC, Kim JW. The effective method for gammaglobulin isolation from bovine colostrum. Korean J Anim Sci 1995; 37: 514-520.

Levieux D, Ollier A. Bovine immunoglobulin G, ?-lactoglobulin, ?-lactalbumin and serum albumin in colostrum and milk during the early post partum period. J Dairy Res 1999; 66:421-430.

Li-Chan EC, Kummer A. Influence of standards and antibodies in immunochemical assays for quantitation of immunoglobulin G in bovine milk. J Dairy Sci 1997; 80:1038-1046.

Li-Chan E, Kummer A, Losso JN, Kitts DD, Nakai S. Stability of bovine immunoglobulins to thermal treatment and processing. Food Res Int 1995; 28: 9-16.

Li-Chan E, Kwan L, Nakai S. Isolation of immunoglobulins by competitive displacement of cheese whey proteins during metal chelate interaction chromatography. J Dairy Sci 1990; 73:2075-2086.

Lindmark Månsson H. Utvinning av bioaktiva komponenter ur kolostrum. 1993. Internal report, SMR.

Lindmark Månsson H. Den svenska mejerimjölkens sammansättning. 1999. Internal report, SMR.

Lindstroem P, Paulsson M, Nylander T, Elofsson U, Lindmark-Mansson H. The effect of heat treatment on bovine immunoglobulins. Milchwissenschaft 1994; 49: 67-71.

Linggood MA, Porter P, Powell JR. Production of antibodies. 1984; European Patent no.0102831.

Lissner R, Schmidt H, Karch H. A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC- hemolysin of Escherichia coli O157: H7. Infection 1996; 24: 378-383.

Lissner R, Thurmann PA, Merz G, Karch H. Antibody reactivity and fecal recovery of bovine immunoglobulins following oral administration of a colostrum concentrate from cows (Lactobin) to healthy volunteers. Int J Clin Pharmacol Ther 1998; 36: 239-245.

Loimaranta V, Carlen A, Olsson J, Tenovuo J, Syväoja E-L, Korhonen H. Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. J Dairy Res 1998; 65:599-607.

Mainer G, Dominguez E, Randrup M, Sanchez L, Calvo M. Effect of heat treatment on anti-rotavirus activity of bovine colostrum. J Dairy Res 1999; 66: 131-137.

Mancini GA, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Imunochem 1965; 2: 235.

Marcotty C, Frankenne F, Van Beeumen J, Maghuin-Rogister G, Hennen G. Insulin-like growth factor 1(IGF-1) from cow colostrum: purification and characterization. Growth Regul 1991; 1:56-61.

Maunsell FP, Morin DE, Constable PD, Hurley WL, McCoy GC, Kakoma I, Isaacson RE. Effects of mastitis on the volume and composition of colostrum produced by Holstein cows. J Dairy Sci 1998; 81:1291-1299.

McClead RE, Gregory SA. Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infect Immun 1984; 44: 474-478.

McGuirk SM. Colostrum: quality and quantity. Cattle Practice 1998; 6: 63-66.

McIntosh GH, Royle PJ, Le Leu RK, Regester GO, Johnson MA, Grinsted RL, Kenward RS, Smithers GW. Whey proteins as functional food ingredients? Int Dairy J 1998; 8:425-434.

Mechor GD, Grohn YT, McDowell LR, Van Saun RJ. Specific gravity of bovine colostrum immunoglobulins as effected by temperature and colostrum components. J Dairy Sci 1992; 75: 3131-3135.

Mero A, Miikkulainen H, Riski J, Pakkanen R, Aalto J, Takala T. Effects of bovine colostrum supplementation on serum IGF-1, IgG, hormone, and saliva IgA during training. J Appl Physiol 1997; 83: 1144-1151,

Milton KI, Hicks CL, O’Leary K and Langlois BE. Effect of lecithin addition and homogenization on bulk starter agglutination. J Dairy Sci 1990; 73: 2259-2264.

Muller LD, Ellinger DK. Colostral immunoglobulin concentrations among breeds of dairy cattle. J Dairy Sci 1981; 64: 1727-1730.

Nash GS, Macdermott RP, Schloemann S, Bertovich MJ, O’Neal J, Porter L, Kulczycki A. Bovine IgG1, but not IgG2, binds to human B cells and inhibits antibody secretion. Immunology 1990; 69:361-366

Ohta M, Sazaki I, Murakami U, Uchiwa H. A new method for improving productivity of colostrum specific IgG by immunization of cows with an antigen- antibody complex. Animal Sci Techn 1998; 69: 612-619.

Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998; 26:1324-1329.

Ouchterlony O. Diffusion-in-gel methods for immunological analysis II. Prog Allergy 1962; 6:30.

Pakkanen R. Determination of transforming growth factor-beta2 (TGF-beta2) in bovine colostrum samples. J Immunoassay 1998; 19: 23-37.

Pakkanen R, Aalto J. Growth factors and antimicrobial factors of bovine colostrum. Int Dairy J 1997; 7: 285-297.

Petshow BW, Talbott RD. Reduction in virus-neutralizing activity of a bovine colostrum immunoglobulin concentrate by gastric acid and digestive enzymes. J Ped Gastroenterol Nutr 1994; 19:228-235.

Playford RJ, Floyd DN, Macdonald CE, Calnan DP, Adenekan RO, Johnson W, Goodlad RA, Marchbank T. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 1999; 44: 653-658.

Pritchett LC, Gay CC, Besser TE, Hancock DD. Management and production factors influencing immunoglobulin G1 concentration in colostrum from Holstein cows. J Dairy Sci 1991; 74: 2336-2341.

Quigley JD, Martin KR, Dowlen HH, Wallis LB, Lamar K. Immunoglobulin concentration, specific gravity, and nitrogen fractions of colostrum from Jersey cattle. J Dairy Sci 1994; 77:264-269.

Reddy NR, Roth SM, Eigel WN, Pierson MD. Foods and food ingredients for prevention of diarrheal disease in children in developing countries. J Food Protect 1988; 51: 66-75.

Rogers M-L, Goddard C, Regester GO, Ballard FJ, Belford DA. Transforming growth factor ? in bovine milk: concentration, stability and molecular mass forms. J Endocrinol 1996; 151:77-86.

Roos N, Mané S, Benamouzig R, Sick H, Rautureau J, Tomé D. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 1995; 125: 1238-1244.

Rudbo M, Ängmo E. Råmjölk. Humanekologiska rapporter 1989; 13.

Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. New Engl J Med 1990; 323: 1-6.

Saif LI, Smith KL, Landmeier BJ, Bohl EH, Theil KW, Todhunter DA. Immune response of pregnant cows to bovine rotavirus immunization. Am J Vet Res 1984; 45: 49-58.

Saito T, Itoh T, Adachi S. Chemical structure of three neutral trisaccharides isolated in free form from bovine colostrum. Carbohydr Res 1987; 165:43-51.

Saito T, Itoh T, Adachi S. Presence of two neutral disaccharides containing N-acetylhexosamine in bovine colostrum as free form. Biochim Biophys Acta 1984; 801:147-150.

Sarker SA, Casswall TH, Mahalanabis D, Alam NH, Albert MJ, Brussow H, Fuchs GJ, Hammerström L. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J 1998; 17:1149-1154.

Scammell AW. Liquid colostrum for dairy products. Patent WO 97/16977 (int publ numb). 1997.

Scheuble TL, Kondo JK, Salih MA. Agglutination behavior of lactic streptococci. J Dairy Sci 1981; 72:1103-1111.

Smithers GW, Ballard FJ, Copeland AD, De Silva KJ, Dionysius DA, Francis GL, Goddard C, Grieve PA, Mcintosh GH, Mitchell IR, Pearce RJ, Regester GO. New opportunities from the isolation and utilization of whey proteins. Symposium: Advances in dairy foods processing and engineering. J Dairy Sci 1996; 79:1454-1459.

Srivastava S, Srivastava RP, Kulsrestha DC. Studies on a cheese like product (Azaco-cheese) made from cow-colostrum. Indian Dairyman 1984; 36:378-.

Steward M, Male D. Immunological techniques. In: Immunology by Roitt I, Brostoff J, Male D. 1989, Second edition. Gower Medical Publishing, England.

Stott GH, Fleenor WA, Kleese WC. Colostral immunoglobulin concentration in two fractions of first milking postpartum and five additional milkings. J Dairy Sci 1981; 64: 459-465.

Tokuyama Y, Tokuyama H. Purification and identification of TGF-beta2-related growth factor from bovine colostrum. J Dairy Res 1993; 60: 99-109.

Turner M. Molecules which recognize antigen. In: Immunology by Roitt I, Brostoff J, Male D. 1989, Second edition. Gower Medical Publishing, England.

Ustunol Z, Sypien C. Heat stability of bovine milk immunoglobulins and their ability to bind lactococci as determined by an ELISA. J Food Sci 1997; 62: 1218-1222.

Vacher PY, Blum JW. Age-dependency of insulin-like growth factor 1, insulin, protein and immunoglobulin concentrations and ?-glutamyl-transferase activity in first colostrum of dairy cows. Milchwissenschaft 1993; 4: 423-426.

Vander A, Sherman J, Luciano D. Human physiology. The mechanism of body function. Seventh edition. McGraw-Hill Companies. 1998; pp.104, 613.

Vyshemirskij FA, Abrosimova SV. The method of manufacture sweet cream butter from bovine colostrum. Patent SU 1597145 A1.

Walstra P, Geurts TJ, Noomen A, Jellema A, van Boekel MAJS. Dairy Technology: Principles of Milk Properties and Processes. 1999. Marcel Dekker, Inc.

Walstra P, Jenness R. Dairy chemistry and physics. 1984. New York: Wiley.

Warny M, Fatimi A, Bostwick EF, Laine DC, Lebel F, LaMont JT, Pothoulakis C, Kelly CP. Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxine neutralising activity after passage through the human stomach and small intestine. Gut 1999; 44:212-217.

Weiner C, Pan Q, Hurtig M, Borén T, Bostwick E, Hammarström L. Passive immunity against human pathogens using bovine antibodies. Unpublished manuscript. 1999.

Wit JN de. Nutritional and functional characteristics of whey proteins in food products. J Dairy Sci 1998; 81: 597-608.

Ylitalo S, Uhari M, Rasi S, Pudas J, Leppäluoto J. Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. Acta Pediatr 1998; 87: 264-267.

Zhihui Z, Kuixiong S, Bixia P, Lunan S, Xiuxian X, Hong H. A study on the anti-aging effect of bovine colostrum extract in the elderly. Acta Nutrimenta Sinica 1994; 16:169-173.

Zinkernagel RM, Hilpert H, Gerber H. The digestion of colostral bovine immunoglobulins in infants. Experientia 1972; 28:741-.

For Additional Links: www.scholar.google.com keywords: Colostrum

Akita EM, Li-Chan EC. Isolation of bovine immunoglobulin G subclasses from milk, colostrum, and whey using immobilized egg yolk antibodies. J Dairy Sci 1998; 81: 54-63.

George-Nascimento, C., Lowenson, Jonathan, Borissenko, M., Calderon, A., Medina-Selby, A., Kuo, J., Clarke, S., Randolph, A. Replacement of a Labile Aspartyl Residue Increases the Stability of Human Epidermal Growth Factor. Biochemistry 29 No. 41(1990) 9584 - 9591.

Antonio J. (1998) Can bovine colostrum enhance levels of IGF-1? Muscle and Fitness Magazine, 1998.

Ballard F, Wallace J, Francis G, Read L, Tomas F. (1996) Des (1-3) IGF-I: a truncated form of insulin-like growth factor-I. International Journal of Cellular Biology. 28:1085-1087.

Bergerot, I, et al. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes. Diabetes & Metabolism 22(4):235-239 (1996). The development of autoimmune diabetes in experimental mice was significantly reduced in those receiving IGF-1 as compared to insulin.

Bhora F, Dunkin B, Batzri S, et al. (1995) Effect of growth factors on cell proliferation and epithelialization in human skin. Journal of Surgery Res. 59:236-244.

Bhora, Y, et al. Effect of growth factors on cell proliferation and epithelialization in human skin. Journal of Surgical Research 59(2):236-244 (1995). Fibroblast growth factor (FGF), IGF-1 and epithelial growth factor (EGF) are important factors in healing skin wounds. EGF in particular is capable of initiating epithelial growth.

Bricker D. (1991) Colostrum: Implications for accelerated recovery in damaged muscle and cartilage, prevention of some pathogenic disease. The American Chiropractor.

Burrin D, Davis T, Ebner S, Schoknecht P, Fiorotto M, Reeds P. (1997) Colostrum enhances the nutritional stimulation of vital organ protein synthesis in neonatal pigs. American Society for Nutritional Sciences.127(7):1284-9.

Burrin DG, Shulman RJ, Reeds PJ, Davis TA, Gravitt KR. (1992) Porcine colostrum and milk stimulate visceral organ and skeletal muscle protein synthesis in neonatal piglets. Journal of Nutrition. 122:1205-1213.

Cass TL. Insulin-like growth factor-1 (IGF-1, Somatomedin C) blood levels are not associated with prostate specific antigen (PSA) levels or prostate cancer: A study of 749 patients. Medical College of Wisconsin, Milwaukee, WI.

Demarco C. (1998) Anti-aging breakthrough: Homeopathic growth factors. Let's Live.

Dohm, GL, et al. IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes 39(9):1028-1032 (1990). IGF-1 stimulates glucose transport by IGF-1 receptors in skeletal muscle, thus alleviating the hyperglycemia observed in non-insulin-dependent diabetes mellitus (NIDDM). Significantly, muscle from obese patients was resistant to this effect.

Donovan, SM, Hartke, JL, Monaco, MH, Wheeler, MB. (2004) Insulin-like Growth Factor-I and Piglet Intestinal Development. Journal of Dairy Science 87(E Suppl.):E46-54. Piglets suckling from IGF-1 transgenic sows (i.e. sows that have been transgenically altered to overexpress IGF-1 in their milk) showed increased villus growth and disaccharidase activity, indicating improved intestinal health.

Francis G, Read L, Ballard J, et al. (1986) Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum. Journal of Biochemistry. 233:207-213.

Francis G, Upton F, Ballard J, McNeil K, Wallace J. (1988) Insulin-like growth factors 1 and 2 in bovine colostrum. Journal of Biochemistry. 251:95-103.

Fryburg D. (1995) Insulin and insulin-like growth factor 1 enhance human skeletal muscle protein anabolism during Hyperaminoacidemia by different mechanisms. Journal of Clinical Investigations. 96:1722-1729.

Ginjala V, Pakkanen R. (1998) Determination of transforming growth factor-B1 (TGF-B1) and insulin-like growth factor 1 (IGF-1) in bovine colostrum samples. Journal of Immunoassay. 19:195-207.

Handsell KL, Baumrucker CR, Kensinger RS. (1993) Effects of elevated blood insulin-like growth factor-I (IGF-I) concentration upon IGF-I in bovine mammary secretions during the colostrum phase. Journal of Endocrinology. 137:223-230.

Hasdai, D, et al. Insulin and insulin-like growth factor I cause coronary vasorelaxation in vitro. Hypertension 32:228-234 (1998). IGF-1 and insulin affect vasorelaxation in coronary arteries, possibly by activating potassium channels.

Hyde, C, et al. Insulin-like Growth Factors (IGF) and IGF-Binding Proteins Bound to Vitronectin Enhance Keratinocyte Protein Synthesis and Migration. Journal of Investigative Dermatology 122(5):1198-1206 (2004). IGF-II binds directly to vitronectin, a component of the extracellular skin matrix, to enhance protein synthesis and migration by skin cells in wound healing and skin regeneration.

Juskevich J. (1990) Bovine Growth Hormone: Human Food Safety Evaluation. Science. 249:875-883.

Kirkpatrick CH. (1993) Structural nature and function of transfer factors. Annals New York Academy of Sciences. 685:362-8.

Marcotty C, Frankenne F, Van Beeumen J, Maghuin-Rogister G, Hennen G. (1991). Insulin-like growth I (IGF-I) from cow colostrum: Purification and characterization. Growth Regulation. 1(2):56-61.

Marquardt H, Lioubin MN, Ikeda T. (1987) Complete amino acid sequence of human transforming growth factor type beta 2. Journal of Biological Chemistry. 262:12127-12131.

Mero A, Kahkonen J, Nykanen T, Parviainen T, Jokinen I, Takala T, Nikula T, Rasi S, Leppaluoto J. Appl Physiol. 2002 Aug;93(2):732-9. Related Articles, IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training. Journal of Applied Physiology, Vol. 83, No. 4, pp. 1144-1151, October 1997

Miers W, Barrett E. (1998) The role of insulin and other hormones in the regulation of amino acid and protein metabolism in humans. Journal of Basic and Clinical Physiology and Pharmacology. 9(2-4):235-53.

Noda K, Umeda M, Ono T. (1984) Transforming growth factor activity in human colostrum. Gann. 75:109-12.

Nowak J, Olszewski J, Kozal E. (1994) Insulin and sugar concentration changes in mammary secretion in sheep during the periparturient period. Reprod. Nutritional Development. 34:3-8.

Nowak J. (1990) Insulin and glucose concentration changes in newborn piglets after suckling the colostrum from insulin administered sows. Acta Physiol. 41(7):155-62.

Oda S, Satoh H, Sugawara T, et al. (1989) Insulin-like growth factor-I, GH, insulin and glucagon concentrations in bovine colostrum and in plasma of dairy cows and neonatal calves around parturition. Comp. Biochemical Physiology. 94A:805-808.

Oda, S., et al., Insulin-like growth factor-l (IGF-1), growth hormone (GH), insulin and glucagon concentrations in bovine colostrum and in plasma of dairy cows and neonatal calves around parturition. Comp. Biochem. Physiol. 1989. 94A(4): p. 805-808.

Oz, HS, Ray, M, Chen, TS, McClain, CJ. (2004) Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease. Journal of the American College of Nutrition 23(3):220-6. Mice with an experimentally-induced inflammatory bowel disease fed a diet rich in transforming growth factor beta-2 (TGF-ß2) gained more weight, did not develop diarrhea or prolapse, had lower pathological scores and lower serum amyloid (SAA). This study supports the use of TGF-ß2 diets in the treatment of Crohn’s disease.

Pakkanen R, Aalto J. (1997) Review paper: Growth factors and antimicrobial factors of bovine colostrum. International Dairy Journal. 7:285-297.

Pakkanen R. (1998) Determination of transforming growth factor-fl2 (TGF-fl2) in bovine colostrum samples. Journal of Immunoassay. 19:23-37.

Rosenthal S, Brown E, Brunetti A, Goldfine I. (1991) Fibroblast growth factor inhibits insulin-like growth factor-II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells. Molecular Endocinology. 5:678-684.

Rudman, D.; et al. Effects of Human Growth Hormone in Men over 60 Years Old. N. Eng. J. Med. 323:1-6, 1990.

Rudman, D, et al. Effects of human growth hormone in men over 60 years old. New England Journal of Medicine 323(1):1-6 (1990). The decline in activity of the growth hormone-IGF-1 system may be related to the loss of lean muscle mass and increase in fat mass with aging. Administration of growth hormone to men over 60 years of age resulted in increased IGF-1 levels in the blood similar to that found in much younger men, increase lean body mass, decreased fat mass and an increase in skin thickness.

Russell, JW, Feldman, EL. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Hormone and Metabolic Research 31(2-3):90-96 (1999). Using an experimental in vitro rat superior cervical ganglion model of diabetic neuropathy, high levels of glucose, such as are found in uncontrolled diabetes, inhibits neurite (cell processes growing from nerve cells in cultures) growth, reduction in neurite size, beading of neurites, neurite retraction and apoptosis (cell death) in neurons. This is reversed by IGF-1 which exhibits a neuroprotective effect on these neurons. This suggests that IGF-1 may be of use in preventing diabetic neuropathy in vivo.

Sara VR, Hall K. (1990) Insulin-like growth factors and their binding proteins. Physiological Reviews. 70:591-606.

Shimizu M, Webster C, Morgan DO, Blau HM, Roth RA. (1986) Insulin and insulin-like growth factor receptors and responses in cultured human muscle cells. American Journal of Physiology. 251:E611-5.

Shing Y, Klagsbrun M. (1987) Purification and characterization of a bovine colostrum-derived growth factor. Molecular Endocrinology. 1:335-338.

Skottner A, Arrhenius-Nyberg V, Kanje M, Fryklund L. (1990) Anabolic and tissue repair functions of recombinant insulin-like growth factor I. Acta Pediatric Scand. 367:63-66.

Sporn M, Roberts A, Shull J, Smith J, Ward J. (1983) Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science. 219(4590):1329-31.

Shomali M, Wolfsthal S. (1997) The use of anti-aging hormones.